logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Advances In Diagnosis And Management Of Cutaneous Adverse Drug Reactions Current And Future Trends 1st Ed Neil H Shear

  • SKU: BELL-7328394
Advances In Diagnosis And Management Of Cutaneous Adverse Drug Reactions Current And Future Trends 1st Ed Neil H Shear
$ 31.00 $ 45.00 (-31%)

4.7

106 reviews

Advances In Diagnosis And Management Of Cutaneous Adverse Drug Reactions Current And Future Trends 1st Ed Neil H Shear instant download after payment.

Publisher: Springer Singapore,Adis
File Extension: PDF
File size: 9.54 MB
Author: Neil H. Shear, Roni P. Dodiuk-Gad
ISBN: 9789811314889, 9789811314896, 9811314888, 9811314896
Language: English
Year: 2019
Edition: 1st ed.

Product desciption

Advances In Diagnosis And Management Of Cutaneous Adverse Drug Reactions Current And Future Trends 1st Ed Neil H Shear by Neil H. Shear, Roni P. Dodiuk-gad 9789811314889, 9789811314896, 9811314888, 9811314896 instant download after payment.

This resource guides prescribers, pharmacists, and regulators with an update on the recent expansion of basic and clinical knowledge that forms a framework for understanding cutaneous reactions. This understanding will lead, in turn, to better outcomes and decisions in treatment and management, both in the clinic and in the life cycle of drug development.
The skin is a common target for adverse drug events and even mild rashes can be part of life-threatening syndromes. Patients and practitioners often face important decisions about therapy after a drug eruption, including treatment, cross-reactivity with future pharmaceuticals, genetic considerations and dealing with long-term sequelae after a reaction. An international team of experts and leaders in the field share their story and insights into the scientific details and relevant clinical context.

Related Products